[go: up one dir, main page]

WO2025015222A3 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions Download PDF

Info

Publication number
WO2025015222A3
WO2025015222A3 PCT/US2024/037678 US2024037678W WO2025015222A3 WO 2025015222 A3 WO2025015222 A3 WO 2025015222A3 US 2024037678 W US2024037678 W US 2024037678W WO 2025015222 A3 WO2025015222 A3 WO 2025015222A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
pharmaceutical composition
agent
lipophilic oil
further include
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/037678
Other languages
French (fr)
Other versions
WO2025015222A2 (en
Inventor
Brett Hale Davis
Caleb Adrian Lade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rebel Medicine Inc
Original Assignee
Rebel Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rebel Medicine Inc filed Critical Rebel Medicine Inc
Publication of WO2025015222A2 publication Critical patent/WO2025015222A2/en
Publication of WO2025015222A3 publication Critical patent/WO2025015222A3/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical composition can include a lipophilic oil. The pharmaceutical composition can further include an analgesic agent, anesthetic agent, anti-inflammatory agent, or a mixture thereof dispersed in the lipophilic oil. The pharmaceutical composition can further include a structuring agent at least a portion of which is not dissolved in the lipophilic oil and forms a gel.
PCT/US2024/037678 2023-07-12 2024-07-11 Pharmaceutical compositions Pending WO2025015222A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363513329P 2023-07-12 2023-07-12
US63/513,329 2023-07-12

Publications (2)

Publication Number Publication Date
WO2025015222A2 WO2025015222A2 (en) 2025-01-16
WO2025015222A3 true WO2025015222A3 (en) 2025-04-03

Family

ID=94216376

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/037678 Pending WO2025015222A2 (en) 2023-07-12 2024-07-11 Pharmaceutical compositions

Country Status (1)

Country Link
WO (1) WO2025015222A2 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20180344663A1 (en) * 2017-06-06 2018-12-06 NC3 Systems Cannabis-based therapeutic product for treatment of chronic pain
US20200069583A1 (en) * 2017-06-22 2020-03-05 Sichuan University In situ phase change gel sustained-release system for small molecule drug and preparation method thereof
US20210106707A1 (en) * 2017-03-27 2021-04-15 Regeneron Pharmaceuticals, Inc. Sterilisation method
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
US20210212946A1 (en) * 2018-01-03 2021-07-15 Icdpharma Ltd. Solid self-emulsifying cannabinoid compositions
CN113827547A (en) * 2020-06-23 2021-12-24 南京清普生物科技有限公司 Sustained-release preparation composition
WO2022217147A1 (en) * 2021-04-09 2022-10-13 Rosenfeld Mark J Methods for improving cutaneous permeation of cannabinoids and fatty acid amides

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20210106707A1 (en) * 2017-03-27 2021-04-15 Regeneron Pharmaceuticals, Inc. Sterilisation method
US20180344663A1 (en) * 2017-06-06 2018-12-06 NC3 Systems Cannabis-based therapeutic product for treatment of chronic pain
US20200069583A1 (en) * 2017-06-22 2020-03-05 Sichuan University In situ phase change gel sustained-release system for small molecule drug and preparation method thereof
US20210212946A1 (en) * 2018-01-03 2021-07-15 Icdpharma Ltd. Solid self-emulsifying cannabinoid compositions
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
CN113827547A (en) * 2020-06-23 2021-12-24 南京清普生物科技有限公司 Sustained-release preparation composition
WO2022217147A1 (en) * 2021-04-09 2022-10-13 Rosenfeld Mark J Methods for improving cutaneous permeation of cannabinoids and fatty acid amides

Also Published As

Publication number Publication date
WO2025015222A2 (en) 2025-01-16

Similar Documents

Publication Publication Date Title
MA29744B1 (en) SOLID DOSAGE FORMULATIONS OF MEDICAMENTS HAVING IMPROVED ORAL ADSORPTION
GT200100039A (en) INHIBITOR OF THE GLUCOGENO FOSFORILASA.
CN1116862C (en) Water-in-oil emulsifier composition
WO2004010941A3 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
EA200301019A1 (en) ORGANIZED PHARMACEUTICAL COMPOSITION, INCLUDING A DRUG WITH LOW SOLUBILITY IN WATER (COX-2 INHIBITOR), SOLVENT, FATTY ACID, AND ORGANIC AMINE
DE60105448D1 (en) SOLID DISPERSIONS WITH NITRATIVE ACTIVE INGREDIENTS
MXPA04007980A (en) Taste-masked film-type or wafer-type medicinal preparation.
BR9813947A (en) Topical compositions for drug distribution nasi
BRPI0414655A (en) pharmaceutical composition and use thereof
ES2185179T3 (en) PREPARATION OF PHARMACEUTICAL COMPOSITIONS.
AR035735A1 (en) PHARMACEUTICAL COMPOSITION THAT CAN BE ADMINISTERED BY ORAL, AND THE USE OF THE SAME IN THE MANUFACTURE OF A MEDICINAL PRODUCT
DE60321774D1 (en) AEROSOL FORMULATIONS OF FORMOTEROL AND MOMETASON
BR122012030846B8 (en) non-aqueous pharmaceutical composition for dermatological use comprising calcipotriol and at least one corticosteroid, and use thereof
CO5251419A1 (en) NANOPARTICULATED COMPOSITIONS OF EPLERENONA
BR0210595A (en) Dosage regimen and pharmaceutical composition for emergency contraception
CA2528649A1 (en) Analgesic and anti-inflammatory patch
WO2005004915A3 (en) Compositions comprising meloxicam
IS7311A (en) A pharmaceutical composition comprising cyclosporin and its use
BRPI0515070B8 (en) butylphthalide self-emulsifying drug delivery system and process for preparing butylphthalide self-emulsifying drug delivery system
WO2025015222A3 (en) Pharmaceutical compositions
FR2407207A1 (en) NEW TETRAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BRPI0407438A (en) Therapeutic system comprising amoxicillin and clavulanic acid
JPH1129482A (en) Pharmaceutical composition
MX2024009290A (en) Pharmaceutical compositions for treating pain.
BR0006556A (en) Pharmaceutical composition for topical use of corticosteroids for the treatment of phimosis